11. Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study. Issue 12 (December 2018) Authors: Lip, Gregory Y.H.; Keshishian, Allison; Li, Xiaoyan; Hamilton, Melissa; Masseria, Cristina; Gupta, Kiran; Luo, Xuemei; Mardekian, Jack; Friend, Keith; Nadkarni, Anagha; Pan, Xianying; Baser, Onur; Deitelzweig, Steven Journal: Stroke Issue: Volume 49:Issue 12(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US. (2nd November 2019) Authors: Amin, Alpesh; Deitelzweig, Steven; Bucior, Iwona; Lin, Jay; Lingohr-Smith, Melissa; Menges, Brandy; Neuman, W. Richey Journal: Journal of medical economics Issue: Volume 22:Number 11(2019) Page Start: 1119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States. (December 2018) Authors: Deitelzweig, Steven; Guo, Jennifer D.; Hlavacek, Patrick; Lin, Jay; Wygant, Gail; Rosenblatt, Lisa; Gupta, Anu; Pan, Xianying; Mardekian, Jack; Lingohr-Smith, Melissa; Menges, Brandy; Marshall, Alexander; Nadkarni, Anagha Journal: Clinical and applied thrombosis/hemostasis Issue: Volume 24:Number 9(2018)Supplement Page Start: 261S Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19. (2nd November 2022) Authors: Deitelzweig, Steven; Zhu, Julia; Jiang, Jenny; Luo, Xuemei; Keshishian, Allison; Ferri, Mauricio; Rosenblatt, Lisa; Schuler, Patricia; Gutierrez, Cynthia; Dhamane, Amol D. Journal: Current medical research and opinion Issue: Volume 38:Number 11(2022) Page Start: 1891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors. (2nd December 2017) Authors: Deitelzweig, Steven; Neuman, W. Richey; Lingohr-Smith, Melissa; Menges, Brandy; Lin, Jay Journal: Journal of medical economics Issue: Volume 20:Number 12(2017) Page Start: 1217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Payer formulary exclusions of apixaban: how patients respond and potential implications. (2nd November 2022) Authors: Deitelzweig, Steven; Terasawa, Emi; Kang, Amiee; Atreja, Nipun; Hines, Dionne M.; Noman, Ahmed; Luo, Xuemei Journal: Current medical research and opinion Issue: Volume 38:Number 11(2022) Page Start: 1885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Practical Considerations in the Use of Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation. Issue 2 (April 2014) Authors: Deitelzweig, Steven Journal: Cardiovascular therapeutics Issue: Volume 32:Issue 2(2014:Apr.) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis. (3rd June 2021) Authors: Deitelzweig, Steven; Di Fusco, Manuela; Kang, Amiee; Savone, Mirko; Mokgokong, Ruth; Keshishian, Allison; Gutierrez, Cynthia; Cappelleri, Joseph C. Journal: Current medical research and opinion Issue: Volume 37:Number 6(2021) Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. S660 Cost Effectiveness of Andexanet Alfa for Major Gastrointestinal Bleeding Associated With Factor Xa Inhibitors. (October 2021) Authors: Cash, Brooks D.; Goldstein, Joshua N.; Deitelzweig, Steven; Lovelace, Belinda; Christoph, Mary J.; Blissett, Robert S.; Fermann, Gregory J. Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions. Issue 10 (6th October 2016) Authors: Margolis, Jay M.; Deitelzweig, Steven; Kline, Jeffrey; Tran, Oth; Smith, David M.; Bookhart, Brahim; Crivera, Concetta; Schein, Jeff Journal: Journal of the American Heart Association Issue: Volume 5:Issue 10(2016) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗